CN Patent

CN115702936A — 一种芦可替尼组合物及其用途

Assigned to Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd · Expires 2023-02-17 · 3y expired

What this patent protects

本发明涉及一种芦可替尼和/或其药学上可接受的盐的组合物及其用途，所述的芦可替尼组合物包含活性成分芦可替尼或其药学上可接受的盐、二乙二醇单烷基醚、乙醇和/或丙二醇，其具有良好的稳定性和促渗透性。进一步提供一种芦可替尼凝胶，其包含芦可替尼组合物和凝胶基质。芦可替尼组合物和芦可替尼凝胶可用于治疗疾病的效果显著优于市售制剂，所述的疾病为皮炎、银屑病、白癜风、汗腺炎、荨麻疹、斑秃的一种或多种。

USPTO Abstract

本发明涉及一种芦可替尼和/或其药学上可接受的盐的组合物及其用途，所述的芦可替尼组合物包含活性成分芦可替尼或其药学上可接受的盐、二乙二醇单烷基醚、乙醇和/或丙二醇，其具有良好的稳定性和促渗透性。进一步提供一种芦可替尼凝胶，其包含芦可替尼组合物和凝胶基质。芦可替尼组合物和芦可替尼凝胶可用于治疗疾病的效果显著优于市售制剂，所述的疾病为皮炎、银屑病、白癜风、汗腺炎、荨麻疹、斑秃的一种或多种。

Drugs covered by this patent

Patent Metadata

Patent number
CN115702936A
Jurisdiction
CN
Classification
—
Expires
2023-02-17
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.